stoxline Quote Chart Rank Option Currency Glossary
  
RadNet, Inc. (RDNT)
49.78  -0.74 (-1.46%)    04-17 16:00
Open: 50.26
High: 50.68
Volume: 704,459
  
Pre. Close: 50.52
Low: 49.13
Market Cap: 3,686(M)
Technical analysis
2025-04-17 4:51:56 PM
Short term     
Mid term     
Targets 6-month :  59.77 1-year :  64.22
Resists First :  51.17 Second :  54.99
Pivot price 50.96
Supports First :  45 Second :  37.44
MAs MA(5) :  52.02 MA(20) :  50.88
MA(100) :  63.06 MA(250) :  62.85
MACD MACD :  -0.5 Signal :  -0.8
%K %D K(14,3) :  61.3 D(3) :  73.1
RSI RSI(14): 44.2
52-week High :  93.65 Low :  45
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ RDNT ] has closed above bottom band by 34.5%. Bollinger Bands are 30.3% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 50.76 - 51.11 51.11 - 51.38
Low: 48.21 - 48.69 48.69 - 49.05
Close: 49.12 - 49.77 49.77 - 50.26
Company Description

RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems for the diagnostic imaging industry, including picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretation of images in the field of mammography, as well as AI solutions for lung and prostate cancer. As of December 31, 2021, it owned and managed 347 centers in Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York. The company was founded in 1981 and is headquartered in Los Angeles, California.

Headline News

Wed, 16 Apr 2025
RadNet, Inc. to Acquire iCAD, Inc. to Accelerate AI-Powered Earl - GuruFocus

Wed, 16 Apr 2025
RadNet (RDNT) to Acquire iCAD in $103 Million Stock Deal - GuruFocus

Tue, 15 Apr 2025
RadNet, Inc. to Acquire iCAD, Inc. to Accelerate AI-Powered Early Detection and Diagnosis of Breast Cancer - GlobeNewswire

Mon, 14 Apr 2025
RadNet, Inc. (RDNT): “Let’s Take a Pass” Says Jim Cramer - Yahoo Finance

Mon, 07 Apr 2025
Are RadNet, Inc.'s (NASDAQ:RDNT) Mixed Financials Driving The Negative Sentiment? - Yahoo Finance

Fri, 28 Mar 2025
Investors in RadNet (NASDAQ:RDNT) have seen fantastic returns of 477% over the past five years - simplywall.st

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Underperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Underperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Outperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Neutral
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Underperform
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Medical - Diagnostics & Research
Shares Out 74 (M)
Shares Float 66 (M)
Held by Insiders 10.4 (%)
Held by Institutions 88.2 (%)
Shares Short 5,840 (K)
Shares Short P.Month 6,030 (K)
Stock Financials
EPS 0.03
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 12.18
Profit Margin 0.1 %
Operating Margin 6.2 %
Return on Assets (ttm) 2.3 %
Return on Equity (ttm) 3.9 %
Qtrly Rev. Growth 13.5 %
Gross Profit (p.s.) 5.02
Sales Per Share 24.71
EBITDA (p.s.) 3.38
Qtrly Earnings Growth 0 %
Operating Cash Flow 233 (M)
Levered Free Cash Flow 51 (M)
Stock Valuations
PE Ratio 1244.5
PEG Ratio 0
Price to Book value 4.08
Price to Sales 2.01
Price to Cash Flow 15.81
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android